Christopher James Stevens
Chief Operating Officer · ROCKET PHARMACEUTICALS, INC.
- 2025
- Aug 13, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher James Stevens files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Martin Wilson - $335K in RCKT purchases and sales in the last 12 months
- Gaurav Shah - $286K in RCKT purchases and sales in the last 12 months
- Sarbani Chaudhuri - $84K in RCKT purchases and sales in the last 12 months
- Elisabeth Bjork - $34K in RCKT purchases and sales in the last 12 months
- John Militello - $24K in RCKT purchases and sales in the last 12 months
- Jonathan David Schwartz - $8K in RCKT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher James Stevens?
Christopher James Stevens is a corporate insider, tracked as Chief Operating Officer of ROCKET PHARMACEUTICALS, INC. (RCKT). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Christopher James Stevens submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Christopher James Stevens been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($128K) across all tracked filings.
